Ursodiol and Maxipime drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ursodiol (ursodiol) and Maxipime (cefepime hydrochloride). Common drug interactions include graft versus host disease among females and cytokine release syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Ursodiol and Maxipime. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.
What is Ursodiol?
Ursodiol has active ingredients of ursodiol. It is often used in primary biliary cirrhosis. eHealthMe is studying from 19,061 Ursodiol users. Check the latest studies of Ursodiol.
What is Maxipime?
Maxipime has active ingredients of cefepime hydrochloride. eHealthMe is studying from 4,279 Maxipime users. Check the latest studies of Maxipime.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
41 people who take Ursodiol and Maxipime together, and have interactions are studied.

What are the common drug interactions of Ursodiol and Maxipime, by gender? *:
female:
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Platelet count decreased
- White blood cell count decreased
- C-reactive protein increased
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
- Pyrexia (fever)
- Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Bacteraemia (presence of bacteria in the blood)
male:
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Dyspnoea (difficult or laboured respiration)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Agitation (state of anxiety or nervous excitement)
- Headache (pain in head)
- Hypoxia (low oxygen in tissues)
- Pericardial effusion (fluid around the heart)
- Pneumonia
- Acute lymphocytic leukaemia (cancer of the white blood cells)
- Ammonia increased
What are the common drug interactions of Ursodiol and Maxipime, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
- Diarrhoea
- Diarrhoea haemorrhagic (bloody diarrhoea)
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Haematoma (collection of blood outside the blood vessels)
- Pleural effusion (water on the lungs)
- Pyrexia (fever)
- Septic shock (shock due to blood infection)
- Tooth abscess (pus formation in tooth)
10-19:
- Diarrhoea
- Electrocardiogram qt prolonged
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Fatigue (feeling of tiredness)
- Fluid overload (too much fluid in the blood)
- Gallbladder enlargement
- Gastrointestinal oedema (excessive build-up of fluid in the gastrointestinal tract tissues)
- Hallucination (an experience involving the perception of something not present)
- Headache (pain in head)
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
20-29:
n/a
30-39:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Nausea (feeling of having an urge to vomit)
- Pneumonia fungal
- Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
- Rash
40-49:
- Pneumonia
- Erythema (redness of the skin)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Interstitial lung disease
- Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Aggression
- Agitation (state of anxiety or nervous excitement)
- Amblyopia (lazy eye)
- Blood calcium decreased
50-59:
- Febrile neutropenia (fever with reduced white blood cells)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Blood creatinine increased
- Blood pressure decreased
- Blood urea increased
- Body temperature increased
- C-reactive protein increased
- Hypercalcaemia (elevated calcium (ca+) level in the blood)
- Neutropenia (an abnormally low number of neutrophils)
- Respiratory failure (inadequate gas exchange by the respiratory system)
60+:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- C-reactive protein increased
- Diarrhoea
- Fibrin d dimer increased
- Gamma-glutamyltransferase increased
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Hypotension (abnormally low blood pressure)
- Liver disorder (liver diseases)
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
What are the existing conditions these people have? *
- Fever: 11 people, 26.83%
- Liver Disorder (liver diseases): 9 people, 21.95%
- Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 9 people, 21.95%
- Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 8 people, 19.51%
- Constipation: 8 people, 19.51%
- Rashes (redness): 6 people, 14.63%
- Nausea (feeling of having an urge to vomit): 6 people, 14.63%
- High Blood Pressure: 6 people, 14.63%
- Abdominal Pain: 5 people, 12.20%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 12.20%
* Approximation only. Some reports may have incomplete information.
Do you take Ursodiol and Maxipime?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Ursodiol and Maxipime:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ursodiol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Maxipime:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ursodiol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Maxipime and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on ursodiol and cefepime hydrochloride (the active ingredients of Ursodiol and Maxipime, respectively), and Ursodiol and Maxipime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Prevacid cause Systemic Inflammatory Response Syndrome? - 6 seconds ago
- Nasonex and Not Effective for Men aged 40-49 - 43 seconds ago
- Nasonex and Drug Ineffective for Men aged 40-49 - 43 seconds ago
- Connective Tissue Disorder and Pain Exacerbated - 44 seconds ago
- Bupropion Hydrochloride and Temaz drug interactions for men aged 60+ - 53 seconds ago
- Valsartan and Confusional State for Women aged 50-59 - 55 seconds ago
- Drug interactions of Pantoprazole and Elmiron - a minute ago
- Valacyclovir and Cellcept drug interactions for men aged 50-59 - a minute ago
- Tylenol and Swelling Of Fingers for Women aged 60+ - 2 minutes ago
- Tylenol and Toe Swelling for Women aged 60+ - 2 minutes ago